Leflunomide (Arava®)-induced cystoid macular oedema [4]

Rheumatology

Volumn 43, Issue 2, 2004, Pages 246-248

  Barak, Adiel ^a,b   Morse, L S ^a   Schwab, I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHROTECK; DICLOFENAC; IMMUNOMODULATING AGENT; LEFLUNOMIDE; MISOPROSTOL; PREDNISONE; ANTIRHEUMATIC AGENT; ISOXAZOLE DERIVATIVE;

ADULT; ANGIOGRAPHY; CASE REPORT; DRUG WITHDRAWAL; EYE REFRACTION; GASTROINTESTINAL DISEASE; HUMAN; LETTER; MALE; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; RHEUMATOID ARTHRITIS; SCLERITIS; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION; VITREOUS DISEASE; CHEMICALLY INDUCED DISORDER; MIDDLE AGED;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; ISOXAZOLES; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED;

EID: 1242342190     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh005     Document Type: Letter

References (7)

1. Silva Junior HT, Morris RE. Leflunomide and malononitrilamides. Am J Med Sci 1997;313:289-301.
2. Weinblatt ME, Kremer JM, Coblyn JS. Leflunomide plus methotrexate in refractory rheumatoid arthritis: A pilot study. Arthritis Rheum 1997;40(Suppl):126.
3. Schuna AA. Update on treatment of rheumatoid arthritis. J Am Pharm Assoc 1998;38:728-35.
4. Wand M, Gaudio A. Cystoid macular edema associated with ocular hypotensive lipids. Am J Ophthalmol 2002;133:403-5.
5. Warner RE, Bullock JD. Latanoprost induced uveitis. Surv Ophthalmol 1999;43:466-8.
6. Camras CB. Latanoprost may trigger the biosynthesis of endogenous prostaglandins in early postoperative pseudophakias. Arch Ophthalmol 1999;117:1265-6.
7. Baldassano VF. Ocular manifestations of rheumatoid diseases. Curr Opin Ophthalmol 1998;9:85 8.